Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

Study identifies a drug candidate for the treatment of fatty liver disease

There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases.

3 Feb 2023

Knowing your cholesterol level can be a crucial factor in overall health

On a top 10 list of things to do, getting your cholesterol level checked likely doesn't make the cut – but no matter your age, knowing your numbers can be a crucial factor in overall health.

2 Feb 2023

Cancer immunotherapy does not interfere with COVID-19 immunity in vaccinated patients, study shows

Research findings published in Frontiers in Immunology show that cancer immunotherapy does not interfere with COVID-19 immunity in previously vaccinated patients.

31 Jan 2023

Liver cancer treatment can place significant financial burden on patients, analysis shows

Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.

30 Jan 2023

Genetically increasing omega-3 fatty acid production improves glucose balance in obese mice

A new study from researchers at Laval University in Quebec, Canada, shows that genetically increasing omega-3 fatty acid production, without direct gut microbiota contact, improves the balance of insulin and glucagon (glucose balance) in obese mice.

25 Jan 2023

Researchers uncover new mechanism that plays key role in the progression of alcohol-related liver disease

Alcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due to an incomplete understanding of the factors contributing to disease development, liver transplantation is still the only available cure.

24 Jan 2023

Consuming soy flour rich in protein B-conglycinin could reduce LDL cholesterol levels

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study.

23 Jan 2023

UQ researchers identify a cellular pathway to reprogram the body’s immune system

University of Queensland researchers have identified a pathway in cells that could be used to reprogram the body's immune system to fight back against both chronic inflammatory and infectious diseases.

18 Jan 2023

Mercy Medical Center secures top rank from Healthgrades for surgical care in Maryland

Mercy Medical Center ranks #1 in Maryland for Surgical Care and among the Top 5 hospitals in the state for both Joint Replacement and Orthopedic Surgery, Dr. David N. Maine, President and CEO of Mercy Health Services, has announced.

18 Jan 2023

What is the association between fast-food intake and liver steatosis?

Researchers quantified the adverse effects of fast-food intake on liver steatosis in new research.

18 Jan 2023

American Academy of Pediatrics releases the first clinical practice guideline for evaluating and treating childhood obesity

A recent news article published by the American Academy of Pediatrics (AAP) discussed the first clinical practice guideline released by the AAP to effectively and safely evaluate and treat pediatric obesity in children and adolescents.

13 Jan 2023

Eating fast food associated with nonalcoholic fatty liver disease

The new year has begun, and with it, resolutions for change. A study from Keck Medicine of USC published today in Clinical Gastroenterology and Hepatology gives people extra motivation to reduce fast-food consumption.

10 Jan 2023

Hair follicle transplants can rejuvenate scars, study finds

In a new study involving three volunteers, skin scars began to behave more like uninjured skin after they were treated with hair follicle transplants.

6 Jan 2023

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

A panel of US-based experts in cardiology, nephrology, endocrinology, and primary care has prepared specific recommendations for early identification and intervention in obesity, diabetes, and other cardiorenal and metabolic diseases. A detailed report on recommended strategies has been published in the Journal of Diabetes and its Complications.

4 Jan 2023

Incurable liver disease could be reversed with a single drug

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the liver, could be reversed with a single drug.

4 Jan 2023

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Using the latest technologies - including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells - researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD).

4 Jan 2023

Discovery could pave the way for developing therapies to treat nonalcoholic steatohepatitis

UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.

27 Dec 2022

An estimated 19 million US adults living with long-COVID

In a recent study published in the journal Clinical Infectious Diseases, a team of researchers examined the risk factors and prevalence and impact of long coronavirus disease (COVID) among a representative sample of adults in the United States (U.S.) and reported that close to 19 million U.S. adults suffer from long COVID.

26 Dec 2022

Diagnostic technologies in Asia Pacific are key to progress toward health-related SDGs

We are at the halfway point from when we set our ambitious sustainable development goal 3 (SDG3) for good health and well-being by 2030.

23 Dec 2022

Study links NAFLD with brain deterioration and identifies a potential therapeutic target

People with liver disease caused by eating too much sugar and fat could be at increased risk of developing serious neurological conditions like depression or dementia.

22 Dec 2022

Liver Disease News and Research

Further Reading

Study identifies a drug candidate for the treatment of fatty liver disease

Knowing your cholesterol level can be a crucial factor in overall health

Cancer immunotherapy does not interfere with COVID-19 immunity in vaccinated patients, study shows

Liver cancer treatment can place significant financial burden on patients, analysis shows

Genetically increasing omega-3 fatty acid production improves glucose balance in obese mice

Researchers uncover new mechanism that plays key role in the progression of alcohol-related liver disease

Consuming soy flour rich in protein B-conglycinin could reduce LDL cholesterol levels

UQ researchers identify a cellular pathway to reprogram the body’s immune system

Mercy Medical Center secures top rank from Healthgrades for surgical care in Maryland

What is the association between fast-food intake and liver steatosis?

American Academy of Pediatrics releases the first clinical practice guideline for evaluating and treating childhood obesity

Eating fast food associated with nonalcoholic fatty liver disease

Hair follicle transplants can rejuvenate scars, study finds

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

Incurable liver disease could be reversed with a single drug

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Discovery could pave the way for developing therapies to treat nonalcoholic steatohepatitis

An estimated 19 million US adults living with long-COVID

Diagnostic technologies in Asia Pacific are key to progress toward health-related SDGs

Study links NAFLD with brain deterioration and identifies a potential therapeutic target

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News